| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/14/2012 | US8114591 Sensing apparatus and method |
| 02/14/2012 | US8114584 Antireflective coatings for high-resolution photolithographic synthesis of DNA array |
| 02/14/2012 | US8114583 Switch-region: target and method for inhibition of bacterial RNA polymerase |
| 02/14/2012 | US8114582 Fluorescence polarization instruments and methods for detection of exposure to biological materials by fluorescence polarization immunoassay of saliva, oral or bodily fluids |
| 02/14/2012 | US8114580 Simulation of normal fresh blood platelets for reference control |
| 02/14/2012 | US8114509 Metal oxide membrane with a gas-selective compound |
| 02/14/2012 | US8114417 Recombinant protective protein from Streptococcus pneumoniae |
| 02/14/2012 | US8114409 Structural proteins of fish pancreatic disease virus and uses thereof |
| 02/14/2012 | US8114408 Peptide fragments reacting specifically with antibodies against highly pathogenic newcastle disease virus and uses thereof |
| 02/14/2012 | US8114407 Tyrosine kinase receptor epitope for use in identifying modulators for prevention and treatment of renal cancer |
| 02/14/2012 | US8114403 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 02/14/2012 | US8114401 Chlamydia trachomatis antigens |
| 02/14/2012 | US8114397 Stabilized bacterial formulation |
| 02/14/2012 | US8114350 Sensors for detecting substances indicative of stroke, ischemia, infection or inflammation |
| 02/14/2012 | US8114271 Small volume in vitro analyte sensor |
| 02/14/2012 | US8114270 Small volume in vitro analyte sensor |
| 02/14/2012 | US8113035 Method for the detection of gaseous impurities in materials |
| 02/14/2012 | CA2666443C Osteopenia animal model |
| 02/14/2012 | CA2611148C Methods and devices for controlling the impact of short circuit faults on co-planar electrochemical sensors |
| 02/14/2012 | CA2597545C Antibody for assay of adamts13 activity and method for assaying the activity |
| 02/14/2012 | CA2510720C Dna chip comprising a microarray made of microelectrode systems |
| 02/14/2012 | CA2481426C Disposable sub-microliter volume biosensor with enhanced sample inlet |
| 02/14/2012 | CA2353789C Chemically modified enzymes with multiple charged variants |
| 02/13/2012 | DE202011109258U1 Atemalkohol-Analysegerät Breath alcohol analyzer |
| 02/12/2012 | CA2748104A1 Apparatus and method for detecting the presence of a particle of a ferromagnetic metal in a packaging of a paramagnetic material |
| 02/10/2012 | CA2718478A1 System and method of providing product quality and safety |
| 02/09/2012 | WO2012019201A2 Tamper evident point of containment, inventory and accountability system and method |
| 02/09/2012 | WO2012019190A1 Compositions and methods for high-throughput nucleic acid analysis and quality control |
| 02/09/2012 | WO2012019184A2 Compositions and methods for detecting, diagnosing, and treating cancer |
| 02/09/2012 | WO2012019125A2 Biomarkers for prostate cancer and methods for their detection |
| 02/09/2012 | WO2012019118A1 Method and apparatus for automated whole blood sample analyses from microscopy images |
| 02/09/2012 | WO2012019109A1 Oscillating immunoassay method and device |
| 02/09/2012 | WO2012019108A1 Magnetic immunosensor with trench configuration and method of use |
| 02/09/2012 | WO2012019107A1 Magnetic immunosensor and method of use |
| 02/09/2012 | WO2012019104A1 Immunoassay method and device with magnetically susceptible bead capture |
| 02/09/2012 | WO2012019099A2 Follistatin-like-protein-1 as a biomarker for inflammatory disorders |
| 02/09/2012 | WO2012019060A1 Predicting and treating diabetic complications |
| 02/09/2012 | WO2012019031A2 Biomarkers for growth hormone disorders |
| 02/09/2012 | WO2012019012A1 Detection of degradation products of canine nt-probnp |
| 02/09/2012 | WO2012019000A2 Biomarkers for the identification monitoring and treatment of ovarian cancer |
| 02/09/2012 | WO2012018982A2 Methods and kits for modulating tumor invasiveness and metastatic potential |
| 02/09/2012 | WO2012018857A2 Prediction of and monitoring cancer therapy response based on gene expression profiling |
| 02/09/2012 | WO2012018855A2 Systems and methods for immunosorbent assays for single and multiple analytes |
| 02/09/2012 | WO2012018790A2 Dual variable domain immunoglobulins and uses thereof |
| 02/09/2012 | WO2012018777A1 Non-enzymatic glucose sensors based on metal oxide nanomaterials |
| 02/09/2012 | WO2012018639A2 Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
| 02/09/2012 | WO2012018638A2 Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures |
| 02/09/2012 | WO2012018623A2 Self-sustained fluidic droplet cassette and system for biochemical assays |
| 02/09/2012 | WO2012018609A2 Mig6 and therapeutic efficacy |
| 02/09/2012 | WO2012018591A1 Light-weight analyzer for odor recognition |
| 02/09/2012 | WO2012018476A1 Antibodies relating to pivka-ii and uses thereof |
| 02/09/2012 | WO2012018294A1 Method for storage and stabilization of a target substance |
| 02/09/2012 | WO2012018258A1 Markers of febrile seizures and temporal lobe epilepsy |
| 02/09/2012 | WO2012018057A1 Immunochromatography reagent composition, and measurement method using same |
| 02/09/2012 | WO2012017739A1 Amyloid assay device and amyloid assay method |
| 02/09/2012 | WO2012017700A1 Method for screening chronic inflammation suppression agent or cancer metastasis suppression agent having inhibition of bonding of emmprin and s100a9 as indicator |
| 02/09/2012 | WO2012017466A1 Use of hmgb1 as' a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof |
| 02/09/2012 | WO2012017424A1 Chemical sensor |
| 02/09/2012 | WO2012017300A1 Apparatus for estimating post-mortem interval of a corpse |
| 02/09/2012 | WO2012017203A1 Diagnostic method |
| 02/09/2012 | WO2012017198A1 Systems and methods for improved accuracy for temperature correction of glucose results for control solution |
| 02/09/2012 | WO2012017197A1 Apparatus and method for testing multiple samples |
| 02/09/2012 | WO2012017125A1 Method and device for rapid diagnosis of hepatitis a in faecal samples |
| 02/09/2012 | WO2012017081A1 Identification of t cell target antigens |
| 02/09/2012 | WO2012017071A1 Perlecan as a biomarker for renal dysfunction |
| 02/09/2012 | WO2012016948A1 Novel methods for predicting the responsiveness of a patient affected with a tumor to a treatment with a tyrosine kinase inhibitor |
| 02/09/2012 | WO2012016929A1 Mass spectrometric diagnosis of sepsis without blood culture |
| 02/09/2012 | WO2012016713A1 Tumour targeting with polypeptides |
| 02/09/2012 | WO2012016704A1 Methods for the identification of methyltransferase interacting molecules and for the purification of methyltransferase proteins |
| 02/09/2012 | WO2012016673A1 Method for determining the tendency to iron deposition and system therefor |
| 02/09/2012 | WO2012016624A1 Determination of the isotope ratios of carbon and nitrogen in water samples |
| 02/09/2012 | WO2012016350A1 Simultaneous determination of multiple analytes in industrial water system |
| 02/09/2012 | WO2012016333A1 Biomarkers for malaria |
| 02/09/2012 | WO2012016332A1 Prognostic gene signatures for non-small cell lung cancer |
| 02/09/2012 | WO2012016286A1 Sorting mined material |
| 02/09/2012 | WO2011157894A3 Device for simulation |
| 02/09/2012 | WO2011156915A3 Method and system for detecting biological molecules in samples |
| 02/09/2012 | WO2011156912A3 A container, a closure for a container, and a base for a container |
| 02/09/2012 | WO2011156910A3 Antimicrobial silicone-based wound dressings containing particulate chlorhexidine |
| 02/09/2012 | WO2011123776A3 Method for detecting occult blood |
| 02/09/2012 | WO2011115445A3 Biochip |
| 02/09/2012 | WO2011082419A3 Dna sequencing methods and detectors and systems for carrying out the same |
| 02/09/2012 | US20120036590 Interferon-like protein zcyto21 |
| 02/09/2012 | US20120036588 Method for observing gad67-positive cell in transgenic animal |
| 02/09/2012 | US20120036587 Prostate cancer cell lines and their use in screening method |
| 02/09/2012 | US20120035505 System for withdrawing blood |
| 02/09/2012 | US20120035499 Method and apparatus for in vivo collection of circulating biological components |
| 02/09/2012 | US20120035450 Blood coagulation system analyzer, and blood coagulation system analysis method and program |
| 02/09/2012 | US20120035207 Use of GABAA Receptor Agonists for the Treatment of Hearing, Vestibular and Attention Disorders, Intention Tremor and Restless Leg Syndrome |
| 02/09/2012 | US20120035179 Modulators of atp-binding cassette transporters |
| 02/09/2012 | US20120035154 Modulators of Cellular Adhesion |
| 02/09/2012 | US20120035098 Novel antiviral agent |
| 02/09/2012 | US20120035084 Device and method for particle complex handling |
| 02/09/2012 | US20120035083 Antireflective Coatings for High-Resolution Photolithographic Synthesis of DNA Array |
| 02/09/2012 | US20120035074 Methods to determine atherosclerosis regression, plaque stabiliztion and cardiovascular risk |
| 02/09/2012 | US20120035073 Compositions and methods for the treatment of immune related diseases |
| 02/09/2012 | US20120035072 Kaspp (lrrk2) gene, its production and use for the detection and treatment of neurodegenerative disorders |
| 02/09/2012 | US20120035069 Prognosis of breast cancer patients by monitoring the expression of two genes |
| 02/09/2012 | US20120035067 Marker Panels For Idiopathic Pulmonary Fibrosis Diagnosis And Evaluation |
| 02/09/2012 | US20120035066 Conjugated polymers for use in homogeneous and solid state assays |